CN102755598B - 一种治疗急性痛风性关节炎的药物及其制备方法 - Google Patents
一种治疗急性痛风性关节炎的药物及其制备方法 Download PDFInfo
- Publication number
- CN102755598B CN102755598B CN 201210272565 CN201210272565A CN102755598B CN 102755598 B CN102755598 B CN 102755598B CN 201210272565 CN201210272565 CN 201210272565 CN 201210272565 A CN201210272565 A CN 201210272565A CN 102755598 B CN102755598 B CN 102755598B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- gouty arthritis
- acute gouty
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 230000001154 acute effect Effects 0.000 title claims abstract description 26
- 201000005569 Gout Diseases 0.000 title claims abstract description 24
- 206010018634 Gouty Arthritis Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title description 4
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 241001299553 Ilex chinensis Species 0.000 claims description 13
- 241001100935 Ilex purpurea Species 0.000 claims description 13
- 235000003366 Ilex purpurea Nutrition 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000219295 Portulaca Species 0.000 claims description 6
- 241000545442 Radix Species 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 23
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 10
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 10
- 229940116269 uric acid Drugs 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 8
- 231100000614 poison Toxicity 0.000 abstract description 7
- 239000002574 poison Substances 0.000 abstract description 4
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 abstract description 3
- 230000001473 noxious effect Effects 0.000 abstract description 3
- 235000003392 Curcuma domestica Nutrition 0.000 abstract 1
- 244000008991 Curcuma longa Species 0.000 abstract 1
- 241001555026 Euphorbia humifusa Species 0.000 abstract 1
- 235000002710 Ilex cornuta Nutrition 0.000 abstract 1
- 241001310146 Ilex cornuta Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 241001404789 Smilax glabra Species 0.000 abstract 1
- 244000107975 Strychnos nux-vomica Species 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 235000013976 turmeric Nutrition 0.000 abstract 1
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 229960001338 colchicine Drugs 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 3
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 3
- 229960003459 allopurinol Drugs 0.000 description 3
- 210000000544 articulatio talocruralis Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- INYYVPJSBIVGPH-UHFFFAOYSA-N 14-episinomenine Natural products C1CN(C)C2CC3=CC=C(OC)C(O)=C3C31C2C=C(OC)C(=O)C3 INYYVPJSBIVGPH-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- RARWEROUOQPTCJ-RBUKOAKNSA-N cepharamine Natural products C1CC2=CC=C(OC)C(O)=C2[C@@]2(CCN3C)[C@]13C=C(OC)C(=O)C2 RARWEROUOQPTCJ-RBUKOAKNSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 229930002966 sinomenine Natural products 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- MHVJRKBZMUDEEV-UHFFFAOYSA-N (-)-ent-pimara-8(14),15-dien-19-oic acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C1CCC(C=C)(C)C=C1CC2 MHVJRKBZMUDEEV-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XDKLKFULWJYRCB-UHFFFAOYSA-N 7,9-dihydro-3h-purine-2,6,8-trione;sodium Chemical compound [Na].N1C(=O)NC(=O)C2=C1NC(=O)N2 XDKLKFULWJYRCB-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 206010065553 Bone marrow failure Diseases 0.000 description 1
- 240000001829 Catharanthus roseus Species 0.000 description 1
- 206010067671 Disease complication Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- MXYATHGRPJZBNA-KRFUXDQASA-N Isopimaric acid Natural products [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)CC2=CC1 MXYATHGRPJZBNA-KRFUXDQASA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000011610 Pinus tabuliformis Nutrition 0.000 description 1
- 241000018651 Pinus tabuliformis Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- INYYVPJSBIVGPH-QHRIQVFBSA-N Sinomenine Chemical compound C([C@@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-QHRIQVFBSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 1
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000001849 cineol derivatives Chemical class 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- -1 demethyl sinomenine Chemical compound 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- MHVJRKBZMUDEEV-KRFUXDQASA-N sandaracopimaric acid Chemical compound [C@H]1([C@](CCC2)(C)C(O)=O)[C@@]2(C)[C@H]2CC[C@@](C=C)(C)C=C2CC1 MHVJRKBZMUDEEV-KRFUXDQASA-N 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗急性痛风性关节炎的药物,其是由下述重量份配比的原料制成:姜黄10~15份、制马钱子0.3~0.6份、茜草10~15份、松节10~15份、防己5~10份、马齿苋30~60份、地锦草15~30份、四季青15~30份、土茯苓30~60份。本发明以解湿毒、清热毒、化瘀毒为基本出发点,合理选取多味中药原料制成中药药物,能够有效缓解急性痛风性关节炎患者的症状,降低人体内血尿酸含量,对急性痛风性关节炎有显著疗效。
Description
技术领域
本发明涉及一种治疗急性痛风性关节炎的药物及其制备方法。
背景技术
急性痛风性关节炎是一种严重危害人类健康的常见病、多发病。它是嘌呤代谢紊乱及(或)尿酸排泄减少所引起的一组疾病。临床特点是高尿酸血症、反复发作的急性单一关节炎、尿酸钠盐形成痛风石沉积、痛风石等,并且随着生活水平的提高,其发病率有逐渐增加的趋势,而且该病并发症严重,病史长,治疗费用高。
急性痛风性关节炎80%的患者有诱发因素,如:进食过多富含嘌呤的食物、关节局部损伤、寒冷刺激、应用利尿剂等。近70%的患者第一跖趾关节受累,局部出现急性红、肿、热、痛和活动受限。其次为跗跖关节、踝和足跟。下肢多于上肢。症状来势较急,进展迅速,疼痛在数小时达到高峰。患者往往因疼痛剧烈而难以入眠,辗转反侧,甚至不能忍受被单覆盖或周围的震动。体检可见关节局部肿胀、潮红、皮温高及活动受限。若未经恰当治疗,常反复发作,最终发展为痛风性肾病,肾功能衰竭。
目前国内外对本病药物治疗,遇到以下棘手问题:、
1、常用于急性痛风性关节炎的西药药物:秋水仙碱;其为急性发作期的首选药物,应尽早使用。大多数患者症状在服药24~28小时缓解。常见的副作用有胃肠道反应、白细胞减少、骨髓抑制、肝功能异常等。非甾体类抗炎药如消炎痛对于秋水仙碱治疗禁忌、无效或不能耐受,已发作数日的痛风可选用此类药物,对于肾功能不全的患者应注意其副作用。由于痛风性关节炎病史较长,往往几十年甚至终生不愈,稍不注意便可引发急性发作,利用西药治疗不能根治只能临时缓解疼痛,毒副作用大,长期使用会给患者脏器造成极大损害。
2、急性痛风性关节炎属于中医的热痹范畴,是热毒流注关节,或内有蕴热,复感风寒湿邪,与热相搏而致的痹症。历代医家论治热痹多治以清热祛邪,宣痹止痛为主,方用白虎加桂枝汤、升麻汤。热毒盛者,用《千金要方》犀角汤加减。目前采用此种方法及药物治疗急性痛风性关节炎,其效果不明显,往往仍然需要依赖于一些西药,如秋水仙碱等,不但增加了治疗成本,而且秋水仙碱等的毒副作用会给患者脏器造成极大损害。
随着当今生活方式与生存环境的改变,尤其随着秋水仙碱、别嘌呤醇等药物的出现,使急性痛风性关节炎的自然过程发生了很大的变化,湿毒、淤毒、热毒相互交织,相互作用,成为导致急性痛风性关节炎的重要病因和致病因素,并贯穿于该病的始终。采用传统清热祛邪,宣痹止痛等传统的中药治疗,很难达到理想的治疗效果。由此可见,现有治疗药物有待于进一步的改进与发展。
发明内容
基于上述技术问题,本发明提供一种治疗急性痛风性关节炎的药物及其制备方法。
其技术解决方案是:
一种治疗急性痛风性关节炎的药物,其是由下述重量份配比的原料制成:
姜黄10~15份、制马钱子0.3~0.6份、茜草10~15份、松节10~15份、防己5~10份、马齿苋30~60份、地锦草15~30份、四季青15~30份、土茯苓30~60份。
优选各原料的重量份配比为:姜黄12~15份、制马钱子0.4~0.6份、茜草12~15份、松节12~15份、防己6~10份、马齿苋40~60份、地锦草20~30份、四季青20~30份、土茯苓40~60份。
进一步优选各原料的重量份配比为:姜黄12份、制马钱子0.4份、茜草15份、松节15份、防己6份、马齿苋60份、地锦草30份、四季青30份、土茯苓60份。
上述治疗急性痛风性关节炎的药物(汤剂)的制备方法,包括以下步骤:
A、按照上述重量份配比分别称取姜黄、制马钱子、茜草、松节、防己、马齿苋、地锦草、四季青与土茯苓作为原料,混合,然后将混合物置于水中浸泡30分钟,混合物与水的重量比为1∶9;
B、步骤A完成后,将步骤A中的混合物及水煎煮30分钟,然后过滤得到第一滤液及第一滤渣;
C、将步骤B中所得第一滤渣与水按照重量比1∶7的比例混合,煎煮35分钟,然后过滤得到第二滤液及第二滤渣,将第一滤液与第二滤液混合即得汤剂。
本发明药物还可制成丸剂、片剂、散剂、胶囊剂等药剂学上的多种剂型。
本发明的药理及效果如下:
本发明以解湿毒、清热毒、化瘀毒为基本出发点,合理选取多味中药制成中药汤剂,能够有效缓解急性痛风性关节炎患者的症状,降低人体内血尿酸含量,对急性痛风性关节炎有显著疗效。
所选中药原料,姜黄含姜黄素和挥发油,挥发油中含姜黄酮、姜油烯、水芹烯、1,8桉叶素、香桧烯、龙脑、去氢姜黄酮,以及阿拉伯糖、果糖、葡萄糖、脂肪油、淀粉、草酸盐等物质,具有破血行气,通经止痛的功效。制马钱子含有马钱子碱、番木鳖碱等成分,所含的马钱子碱有镇痛、镇静作用,因此具有散结消肿、通络止痛的作用。茜草性寒,味苦,具有活血化瘀之功效。松节主要含纤维素,木质素,少量挥发油(松节油)和树脂;挥发油中α-和β-蒎烯的含量约90%以上,另含少量的樟烯、二戊烯等,还含油脂;油松的松节还含熊果酸与异海松酸;松节具有祛风、镇静止痛、消炎等药理作用。防己具有利水消肿,祛风止痛、解热、消炎、肌肉松弛的功效,其含有多种生物碱,主要为汉防己碱、去甲基汉防己碱。马齿苋具有清热解毒、凉血的功效。地锦草归肺、肝、胃、大肠、膀胱经,具有清热解毒,利湿退黄,活血止血的功效。四季青具有清热解毒,活血止血的功效,其含有的原儿茶酸有明显的抗炎消肿的作用。土茯苓具有解毒,除湿,利关节的功效,根含有生物碱、挥发油、己糖、鞣质、植物甾醇及亚油酸、油酸等成分,现代药理研究表明土茯苓可增加血尿酸的排泄,适用于痛风的防治。
具体实施方式
实施例1
按下述配比称取各中药原料:
姜黄12克、制马钱子0.4克、茜草15克、松节15克、防己6克、马齿苋60克、地锦草30克、四季青30克、土茯苓60克。
制备方法如下:
A、将称取的姜黄、制马钱子、茜草、松节、防己、马齿苋、地锦草、四季青与土茯苓混合,然后将混合物置于2.1千克水中浸泡30分钟;
B、步骤A完成后,将步骤A中的混合物及水煎煮30分钟,然后过滤得到第一滤液及第一滤渣;
C、将步骤B中所得第一滤渣与水按照重量比1∶7的比例混合,煎煮35分钟,然后过滤得到第二滤液及第二滤渣,将第一滤液与第二滤液混合即得汤剂。
实施例2
按下述配比称取各中药原料:
姜黄12克、制马钱子0.4克、茜草12克、松节12克、防己6克、马齿苋40克、地锦草20克、四季青20克、土茯苓40克。
制备方法同实施例1,区别在于:步骤A中,将混合物置于1.5千克水中浸泡。
实施例3
按下述配比称取各中药原料:
姜黄15克、制马钱子0.6克、茜草15克、松节15克、防己10克、马齿苋60克、地锦草30克、四季青30克、土茯苓60克。
制备方法同实施例1。
临床试验
1、临床资料
收治门诊患者200例,随机将患者分为两组,治疗组100例,给予实施例1-3制得的本发明药物治疗,对照组100例,给予现有药物别嘌呤醇治疗。治疗组中40岁以下18例,40-49岁38例,50-59岁27例,60岁以上17例;其中侵犯跖趾关节51例,踝关节33例,其它关节16例,血尿酸408.5~658.0μmol/L,平均530μmol/L。对照组中40岁以下19例,40-49岁40例,50-59岁22例,60岁以上19例;其中侵犯跖趾关节53例,踝关节30例,其它关节17例,血尿酸410.0~680.7μmol/L,平均528μmol/L,血尿酸正常值为150~430μmol/L。两组患者年龄分布、病程、血尿酸值等无显著差异,具有可比性。
2、诊断标准
2.1参照类风湿病协会1977年制定的诊断标准诊断;
2.2中医辨证属热痹者;症见:关节红、肿、热痛,屈伸不利;遇热加剧,得冷稍舒;多夜间发作,痛剧;严重者累及踝及其他小关节,伴发热、口干、尿赤黄、苔黄腻、脉滑数。
全部病例均按上述诊断标准确定诊断。
3、治疗方法
治疗方法是在病人自愿前提下,治疗组患者服用本发明药物汤剂,每日两剂,剂量为300毫升;对照组患者服用别嘌呤醇0.1g,每日3次口服;Vit B1 20mg,每日3次口服,发热及泌尿系结石者对症处理。
两组均以治疗7天为1个疗程,2个疗程后统计治疗结果。
4、疗效评定标准
痊愈:临床症状全部消失,关节活动自如,血尿酸降至正常;
显效:临床症状好转,关节活动灵活,血尿酸较治疗前降低10%以上;
无效:临床症状缓解不明显,血尿酸与治疗前无显著变化。
5、结果与分析
表1
组别 | 例数 | 痊愈 | 显效 | 无效 | 总有效率 |
治疗组 | 100 | 87 | 8 | 5 | 95% |
对照组 | 100 | 50 | 23 | 27 | 73% |
从表1中可以看出,治疗组疗效明显优于对照组。
Claims (4)
1.一种治疗急性痛风性关节炎的药物,其特征在于它是由下述重量份配比的原料制成:
姜黄10~15份、制马钱子0.3~0.6份、茜草10~15份、松节10~15份、防己5~10份、马齿苋30~60份、地锦草15~30份、四季青15~30份、土茯苓30~60份。
2.根据权利要求1所述的一种治疗急性痛风性关节炎的药物,其中各原料的重量份配比是:
姜黄12~15份、制马钱子0.4~0.6份、茜草12~15份、松节12~15份、防己6~10份、马齿苋40~60份、地锦草20~30份、四季青20~30份、土茯苓40~60份。
3.根据权利要求2所述的一种治疗急性痛风性关节炎的药物,其中各原料的重量份配比是:
姜黄12份、制马钱子0.4份、茜草15份、松节15份、防己6份、马齿苋60份、地锦草30份、四季青30份、土茯苓60份。
4.如权利要求1~3中任一权利要求所述药物的制备方法,其特征在于包括以下步骤:
A、按照上述重量份配比分别称取姜黄、制马钱子、茜草、松节、防己、马齿苋、地锦草、四季青与土茯苓作为原料,混合,然后将混合物置于水中浸泡30分钟,混合物与水的重量比为1∶9;
B、步骤A完成后,将步骤A中的混合物及水煎煮30分钟,然后过滤得到第一滤液及第一滤渣;
C、将步骤B中所得第一滤渣与水按照重量比1∶7的比例混合,煎煮35分钟,然后过滤得到第二滤液及第二滤渣,将第一滤液与第二滤液混合即得药物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210272565 CN102755598B (zh) | 2012-08-02 | 2012-08-02 | 一种治疗急性痛风性关节炎的药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210272565 CN102755598B (zh) | 2012-08-02 | 2012-08-02 | 一种治疗急性痛风性关节炎的药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102755598A CN102755598A (zh) | 2012-10-31 |
CN102755598B true CN102755598B (zh) | 2013-10-16 |
Family
ID=47050406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210272565 Expired - Fee Related CN102755598B (zh) | 2012-08-02 | 2012-08-02 | 一种治疗急性痛风性关节炎的药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102755598B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104857350A (zh) * | 2015-05-25 | 2015-08-26 | 孙景云 | 一种治疗急性痛风性关节炎的中药外洗剂及护理方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100443112C (zh) * | 2005-12-06 | 2008-12-17 | 成都中汇制药有限公司 | 一种治疗痛风及痛风性关节炎的药物 |
CN100384462C (zh) * | 2005-12-21 | 2008-04-30 | 苏州市中医医院 | 一种治疗急性痛风性关节炎的药物组合物及其制备方法 |
CN101199779A (zh) * | 2007-12-21 | 2008-06-18 | 北京中科雍和医药技术有限公司 | 一种治疗急性痛风性关节炎的药物组合物及其制备方法 |
CN102293928A (zh) * | 2010-06-22 | 2011-12-28 | 天津市石天药业有限责任公司 | 治疗高尿酸血症及痛风性关节炎的中药组合物及其制备方法与应用 |
-
2012
- 2012-08-02 CN CN 201210272565 patent/CN102755598B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102755598A (zh) | 2012-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104173937A (zh) | 一种疏肝利胆的中药组合物及其应用 | |
CN108853433A (zh) | 一种治疗糖尿病肾病的中药及其制备方法 | |
CN1879709B (zh) | 一种治疗痔疮和肛瘘疾病的中药 | |
CN104758722A (zh) | 一种治疗痛风的中药组合物 | |
CN1239177C (zh) | 一种治疗痔疮的中草药剂 | |
CN103721081A (zh) | 一种治疗痛风的中药组合物 | |
CN102755598B (zh) | 一种治疗急性痛风性关节炎的药物及其制备方法 | |
CN101890062A (zh) | 甘松及其提取物在制备治疗胃溃疡的药物中的用途 | |
CN105250954B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN101129597B (zh) | 一种治疗类风湿关节炎的内服中药 | |
CN103432330A (zh) | 一种治疗肾衰竭的中药及其制备方法 | |
CN101991737A (zh) | 一种胃药 | |
CN103933408A (zh) | 一种治疗急性痛风性关节炎的中药汤剂 | |
CN101590208B (zh) | 一种治疗类风湿关节炎的药物组合物及其制备方法 | |
CN105079708A (zh) | 一种治疗高脂血的中药及其制备方法 | |
CN105327262A (zh) | 一种治疗小儿便秘的中药配方及其制备方法 | |
CN104825916A (zh) | 一种治疗类风湿性关节炎的中药组合物及制备方法 | |
CN105311392A (zh) | 一种治疗三叉神经痛的中药 | |
CN105497634B (zh) | 一种治疗类风湿性关节炎的壮药组合物 | |
CN100998707B (zh) | 一种治疗坐骨神经痛的汤剂药物及制备方法 | |
CN1712055A (zh) | 一种治疗泌尿系结石的中药制剂(溶石胶囊) | |
CN101380414B (zh) | 一种治疗痛风和高尿酸血症的中药组合物及其制备方法 | |
CN101167915B (zh) | 治疗慢性浅表性胃炎的中药组合物及其制备方法 | |
CN101890069A (zh) | 预防和治疗痛风病的药物及其制备工艺 | |
CN105663850A (zh) | 一种治疗口腔溃疡的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131016 Termination date: 20140802 |
|
EXPY | Termination of patent right or utility model |